Rushing DA - Search Results

1

The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer.

Rushing DA, Raber SR, Rodvold KA, Piscitelli SC, Plank GS, Tewksbury DA. Rushing DA, et al. Cancer. 1994 Aug 1;74(3):834-41. doi: 10.1002/1097-0142(19940801)74:3<834::aid-cncr2820740308>3.0.co;2-9. Cancer. 1994. PMID: 8039111

2

High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma.

Rushing DA, Friedenberg WR, Baldauf MC, Broste S, Gehlsen JA, Kriesel DH, Koontz DP, Rodvold KA. Rushing DA, et al. Cancer. 1991 Aug 15;68(4):720-4. doi: 10.1002/1097-0142(19910815)68:4<720::aid-cncr2820680409>3.0.co;2-r. Cancer. 1991. PMID: 1649684

3

Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer.

Piscitelli SC, Rodvold KA, Rushing DA, Tewksbury DA. Piscitelli SC, et al. Among authors: rushing da. Clin Pharmacol Ther. 1993 May;53(5):555-61. doi: 10.1038/clpt.1993.69. Clin Pharmacol Ther. 1993. PMID: 8387903

4

The disposition of doxorubicin on repeated dosing.

Rushing DA, Piscitelli SC, Rodvold KA, Tewksbury DA. Rushing DA, et al. J Clin Pharmacol. 1993 Aug;33(8):698-702. doi: 10.1002/j.1552-4604.1993.tb05609.x. J Clin Pharmacol. 1993. PMID: 8408728

5

Doxorubicin clearance in the obese.

Rodvold KA, Rushing DA, Tewksbury DA. Rodvold KA, et al. Among authors: rushing da. J Clin Oncol. 1988 Aug;6(8):1321-7. doi: 10.1200/JCO.1988.6.8.1321. J Clin Oncol. 1988. PMID: 3411343

6

Multi-drug resistance in chronic lymphocytic leukemia.

Friedenberg WR, Spencer SK, Musser C, Hogan TF, Rodvold KA, Rushing DA, Mazza JJ, Tewksbury DA, Marx JJ. Friedenberg WR, et al. Among authors: rushing da. Leuk Lymphoma. 1999 Jun;34(1-2):171-8. doi: 10.3109/10428199909083394. Leuk Lymphoma. 1999. PMID: 10350346 Clinical Trial.

7

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma.

Villalobos VM, Mo G, Agulnik M, Pollack SM, Rushing DA, Singh A, Van Tine BA, McNaughton R, Decker RL, Zhang W, Shahir A, Cronier DM. Villalobos VM, et al. Among authors: rushing da. Cancer Med. 2020 Feb;9(3):882-893. doi: 10.1002/cam4.2728. Epub 2019 Dec 10. Cancer Med. 2020. PMID: 31821732 Free PMC article. Clinical Trial.

8

A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.

Robins HI, Katschinski DM, Longo W, Grosen E, Wilding G, Gillis W, Kraemer C, Tiggelaar CL, Rushing D, Stewart JA, Spriggs D, Love R, Arzoomanian RZ, Feierabend C, Alberti D, Morgan K, Simon K, d'Oleire F. Robins HI, et al. Cancer Chemother Pharmacol. 1999;43(5):409-14. doi: 10.1007/s002800050915. Cancer Chemother Pharmacol. 1999. PMID: 10100597

9

Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy.

Patel S, Keohan ML, Saif MW, Rushing D, Baez L, Feit K, DeJager R, Anderson S. Patel S, et al. Cancer. 2006 Dec 15;107(12):2881-7. doi: 10.1002/cncr.22334. Cancer. 2006. PMID: 17109446 Free article. Clinical Trial.

10

Phase I/II study of weekly irinotecan and paclitaxel in patients with SCLC.

Rushing DA. Rushing DA. Oncology (Williston Park). 2000 Jul;14(7 Suppl 5):63-6. Oncology (Williston Park). 2000. PMID: 10981293 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters